AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1992
Founded1992
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
213.34B
Market cap213.34B
Price-Earnings ratio
27.63
Price-Earnings ratio27.63
Dividend yield
2.19%
Dividend yield2.19%
Average volume
3.96M
Average volume3.96M
High today
$69.88
High today$69.88
Low today
$68.67
Low today$68.67
Open price
$69.55
Open price$69.55
Volume
2.99M
Volume2.99M
52 Week high
$87.68
52 Week high$87.68
52 Week low
$61.24
52 Week low$61.24

AZN News

TipRanks 8h
AstraZeneca’s Pediatric Hyperkalaemia Study: A Potential Game-Changer

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Ele...

TipRanks 1d
AstraZeneca’s Benralizumab Study: A Potential Game-Changer for Severe Asthma

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Ele...

TipRanks 1d
AstraZeneca’s DAISY Study: A New Hope for Systemic Sclerosis Treatment

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Ele...

Analyst ratings

90%

of 30 ratings
Buy
90%
Hold
10%
Sell
0%

More AZN News

TipRanks 1d
AstraZeneca’s Real-world Study on BGF: A Potential Game Changer for COPD Treatment

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Ele...

TipRanks 1d
AstraZeneca and Bayer’s Collaborative Study on Metastatic Prostate Cancer: A Potential Game-Changer?

AstraZeneca ((AZN)), Bayer AG ((BAYRY)), AstraZeneca plc ((GB:AZN)), Bayer Ag (UK) ((GB:0P6S)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced...

Sherwood News 1d
Britain’s biggest stock index hit a new record this week — what’s actually in there?

The FTSE 100 passed the 9,000-point mark for the first time on Tuesday and so far is outperforming the S&P 500 in 2025. It’s a strange time for the global stoc...

Britain’s biggest stock index hit a new record this week — what’s actually in there?
TipRanks 2d
AstraZeneca’s Anselamimab Trial Shows Mixed Results

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Benzinga 2d
AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition

On Wednesday, AstraZeneca Plc AZN released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) Phase 3 program. The trial showed...

AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition
Benzinga 2d
AstraZeneca's Therapy For Rare Protein Deposit Condition Fails - AstraZeneca - Benzinga

...

AstraZeneca's Therapy For Rare Protein Deposit Condition Fails - AstraZeneca - Benzinga
Seeking Alpha 3d
AstraZeneca’s rare disease drug falls short in late-stage trial

An experimental AstraZeneca (NASDAQ:AZN) drug, anselamimab, failed to extend survival or cut heart-related hospitalizations in patients with a rare plasma cell...

AstraZeneca’s rare disease drug falls short in late-stage trial
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.